Atea Pharmaceuticals Inc Capital Reinvestment Ratio
Atea Pharmaceuticals Inc capital reinvestment ratio. Atea Pharmaceuticals Inc (AVIR) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow ($22.60 Million) in capital expenditures ($4.00K). Check AVIR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Atea Pharmaceuticals Inc (2020–2020)
Capital reinvestment ratio of Atea Pharmaceuticals Inc from 2020 to 2020. This chart tracks Atea Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset growth rate of Atea Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Atea Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2020–2020)
Atea Pharmaceuticals Inc capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see cash flow conversion of Atea Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $296.73 Million | $26.00K | — |